USANA HEALTH SCIENCES INC - Common Stock (USNA)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
USNA on NYSE
Shares outstanding
18,372,545
Price per share
$19.63
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
11,130,949
Total reported value
$306,669,559
% of total 13F portfolios
0%
Share change
+118,509
Value change
+$2,607,149
Number of holders
161
Price from insider filings
$19.63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of USANA HEALTH SCIENCES INC - Common Stock (USNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PZENA INVESTMENT MANAGEMENT LLC 6.6% +18% $33,406,921 +$4,490,060 1,212,588 +16% PZENA INVESTMENT MANAGEMENT LLC 30 Sep 2025
VANGUARD GROUP INC 5.4% -26% $30,090,426 -$10,769,598 1,011,783 -26% The Vanguard Group 30 Jun 2025
DIMENSIONAL FUND ADVISORS LP 5% $25,209,691 915,049 Dimensional Fund Advisors LP 30 Sep 2025
As of 30 Sep 2025, USANA HEALTH SCIENCES INC - Common Stock (USNA) has 161 institutional shareholders filing 13F forms. They hold 11,130,949 shares. of 18,372,545 outstanding shares (61%) .

Top 25 institutional shareholders own 52% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.8% 1,796,321 +0.16% 0% $49,488,645
PZENA INVESTMENT MANAGEMENT LLC 6.6% 1,212,588 +1.2% 0.11% $33,406,799
RENAISSANCE TECHNOLOGIES LLC 6.1% 1,125,530 -2.5% 0.04% $31,008,351
VANGUARD GROUP INC 5.8% 1,069,032 +5.7% 0% $29,451,831
DIMENSIONAL FUND ADVISORS LP 5% 915,049 +1.9% 0.01% $25,209,706
STATE STREET CORP 2.3% 427,493 +0.27% 0% $11,777,432
MORGAN STANLEY 1.8% 327,093 -0.76% 0% $9,011,412
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.6% 288,079 +26% 0% $7,936,576
JACOBS LEVY EQUITY MANAGEMENT, INC 1.4% 264,973 -24% 0.03% $7,300,006
AMERICAN CENTURY COMPANIES INC 1.4% 260,560 +2.2% 0% $7,178,428
GEODE CAPITAL MANAGEMENT, LLC 1.4% 260,206 -16% 0% $7,170,120
TWO SIGMA INVESTMENTS, LP 0.88% 160,933 +350% 0.01% $4,433,704
GOLDMAN SACHS GROUP INC 0.84% 154,538 -7.4% 0% $4,257,522
Nuveen, LLC 0.79% 145,873 +44% 0% $4,018,801
Walleye Capital LLC 0.7% 129,337 +182% 0.03% $3,563,234
Connor, Clark & Lunn Investment Management Ltd. 0.67% 123,325 +26% 0.01% $3,397,604
NORTHERN TRUST CORP 0.65% 119,850 -3.9% 0% $3,301,867
BANK OF AMERICA CORP /DE/ 0.62% 113,139 +55% 0% $3,116,981
Invesco Ltd. 0.6% 109,363 -2% 0% $3,012,950
Assenagon Asset Management S.A. 0.56% 102,187 -2.1% 0% $2,815,252
AMERIPRISE FINANCIAL INC 0.55% 100,729 -33% 0% $2,775,083
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.48% 87,455 +65% 0.05% $2,409,385
Bank of New York Mellon Corp 0.47% 86,992 -2.2% 0% $2,396,631
TWO SIGMA ADVISERS, LP 0.44% 80,300 +470% 0% $2,212,265
ALGERT GLOBAL LLC 0.42% 76,862 +15% 0.04% $2,118,000

Institutional Holders of USANA HEALTH SCIENCES INC - Common Stock (USNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 109,204 $2,143,244 -$1,471,751 $19.63 5
2025 Q3 11,130,949 $306,669,559 +$2,607,149 $27.55 161
2025 Q2 11,019,651 $336,438,295 +$9,242,552 $30.53 165
2025 Q1 10,744,218 $289,815,735 -$1,688,366 $26.97 161
2024 Q4 10,781,518 $386,948,156 +$6,187,917 $35.89 152
2024 Q3 10,595,059 $401,746,677 +$10,654,885 $37.92 145
2024 Q2 10,244,156 $463,458,615 +$5,762,861 $45.24 153
2024 Q1 10,112,945 $490,475,490 -$15,359,710 $48.50 159
2023 Q4 11,010 $590,136 -$9,916 $53.60 1
2023 Q3 10,175,274 $596,360,507 -$314,863 $58.61 154
2023 Q2 10,153,403 $640,064,270 -$19,215,723 $63.04 163
2023 Q1 10,446,439 $657,024,925 +$1,868,591 $62.90 171
2022 Q4 10,467,828 $556,937,914 +$13,270,217 $53.20 162
2022 Q3 10,200,018 $571,763,539 -$14,110,154 $56.05 155
2022 Q2 10,478,807 $755,809,623 +$2,518,426 $72.36 171
2022 Q1 10,472,195 $832,135,755 -$20,167,892 $79.45 168
2021 Q4 10,672,570 $1,079,949,756 -$17,357,710 $101.20 185
2021 Q3 10,783,357 $993,692,867 -$27,502,539 $92.20 176
2021 Q2 10,915,484 $1,117,734,028 -$47,506,391 $102.43 182
2021 Q1 11,472,493 $1,119,438,868 +$17,545,240 $97.60 195
2020 Q4 11,238,822 $866,620,987 -$37,014,965 $77.10 178
2020 Q3 11,874,155 $874,631,911 -$11,372,391 $73.65 182
2020 Q2 12,041,564 $883,962,225 +$55,050,828 $73.43 183
2020 Q1 11,308,070 $653,281,969 -$11,098,020 $57.76 157
2019 Q4 11,423,620 $897,260,342 -$17,511,885 $78.55 166
2019 Q3 11,522,266 $788,454,534 -$154,321,480 $68.39 158
2019 Q2 14,066,274 $1,116,880,915 +$40,719,841 $79.43 163
2019 Q1 14,197,822 $1,190,048,036 +$141,771,564 $83.87 182
2018 Q4 12,415,697 $1,459,203,624 -$120,397,366 $117.73 184
2018 Q3 13,404,395 $1,614,448,588 +$74,111,214 $120.55 193
2018 Q2 12,744,584 $1,468,507,789 +$136,467,938 $115.30 179
2018 Q1 12,067,579 $1,036,576,255 +$44,334,419 $85.90 162
2017 Q4 11,577,692 $857,370,197 +$52,198,861 $74.05 148
2017 Q3 10,639,578 $613,858,641 -$11,687,911 $57.70 138
2017 Q2 11,114,681 $712,472,999 +$54,177,368 $64.10 141
2017 Q1 10,282,191 $592,692,942 +$53,293,283 $57.60 150
2016 Q4 9,946,936 $608,750,814 +$285,654,086 $61.20 148
2016 Q3 5,054,657 $698,954,739 +$462,697 $138.35 138
2016 Q2 5,076,855 $565,690,048 -$19,608,201 $111.43 139
2016 Q1 5,256,236 $637,532,954 -$57,538,571 $121.42 135
2015 Q4 5,729,664 $732,177,500 -$13,030,931 $127.75 158
2015 Q3 5,708,298 $765,126,965 +$42,025,749 $134.03 161
2015 Q2 5,434,320 $742,952,539 -$31,692,083 $136.66 147
2015 Q1 5,700,267 $633,411,271 -$9,605,024 $111.12 141
2014 Q4 5,886,371 $603,911,253 -$26,858,963 $102.59 127
2014 Q3 6,203,933 $456,927,520 -$26,841,197 $73.66 120
2014 Q2 6,511,637 $508,809,772 -$76,901,109 $78.14 119
2014 Q1 7,554,431 $569,233,475 +$40,411,699 $75.34 141